– Exploratory long-term follow-up analysis of the Phase III POLARIX study indicated a positive trend in overall survival in favor of Polivy in combination with R-CHP for people with first-line diffuse ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results